BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rubio-Navarro A, Carril M, Padro D, Guerrero-Hue M, Tarín C, Samaniego R, Cannata P, Cano A, Villalobos JM, Sevillano ÁM, Yuste C, Gutiérrez E, Praga M, Egido J, Moreno JA. CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles. Theranostics 2016;6:896-914. [PMID: 27162559 DOI: 10.7150/thno.14915] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Mccullough KR, Akhter J, Taheri MJ, Traylor A, Zmijewska AA, Verma V, Hudson MC, Sachdeva A, Erman EN, Moore KH, George JF, Bolisetty S. Functional consequence of myeloid ferritin heavy chain on acute and chronic effects of rhabdomyolysis-induced kidney injury. Front Med 2022;9. [DOI: 10.3389/fmed.2022.894521] [Reference Citation Analysis]
2 Hebert JF, Burfeind KG, Malinoski D, Hutchens MP. Molecular mechanisms of rhabdomyolysis-induced kidney injury: from bench to bedside. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.09.026] [Reference Citation Analysis]
3 Zhang Y, Zhang X, Meng Y, Xu X, Zuo D. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype. Int Immunopharmacol 2022;110:108994. [PMID: 35777265 DOI: 10.1016/j.intimp.2022.108994] [Reference Citation Analysis]
4 Tao Q, Zhang D, Zhang Q, Liu C, Ye S, Feng Y, Liu R. Mitochondrial targeted ROS Scavenger based on nitroxide for Treatment and MRI imaging of Acute Kidney Injury. Free Radic Res 2022;:1-32. [PMID: 35746859 DOI: 10.1080/10715762.2022.2093724] [Reference Citation Analysis]
5 Bondue T, van den Heuvel L, Levtchenko E, Brock R. The potential of RNA-based therapy for kidney diseases. Pediatr Nephrol 2022. [PMID: 35507149 DOI: 10.1007/s00467-021-05352-w] [Reference Citation Analysis]
6 Li N, Chen J, Geng C, Wang X, Wang Y, Sun N, Wang P, Han L, Li Z, Fan H, Hou S, Gong Y. Myoglobin promotes macrophage polarization to M1 type and pyroptosis via the RIG-I/Caspase1/GSDMD signaling pathway in CS-AKI. Cell Death Discov 2022;8:90. [PMID: 35228524 DOI: 10.1038/s41420-022-00894-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wong ET, Luettich K, Krishnan S, Wong SK, Lim WT, Yeo D, Büttner A, Leroy P, Vuillaume G, Boué S, Hoeng J, Vanscheeuwijck P, Peitsch MC. Reduced Chronic Toxicity and Carcinogenicity in A/J Mice in Response to Life-Time Exposure to Aerosol From a Heated Tobacco Product Compared With Cigarette Smoke. Toxicol Sci 2020;178:44-70. [PMID: 32780830 DOI: 10.1093/toxsci/kfaa131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
8 Cantero-Navarro E, Rayego-Mateos S, Orejudo M, Tejedor-Santamaria L, Tejera-Muñoz A, Sanz AB, Marquez-Exposito L, Marchant V, Santos-Sanchez L, Egido J, Ortiz A, Bellon T, Rodrigues-Diez RR, Ruiz-Ortega M. Role of Macrophages and Related Cytokines in Kidney Disease. Front Med (Lausanne) 2021;8:688060. [PMID: 34307414 DOI: 10.3389/fmed.2021.688060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
9 Zhao Y, Pu M, Wang Y, Yu L, Song X, He Z. Application of nanotechnology in acute kidney injury: From diagnosis to therapeutic implications. J Control Release 2021;336:233-51. [PMID: 34171444 DOI: 10.1016/j.jconrel.2021.06.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
10 Li N, Wang X, Wang P, Fan H, Hou S, Gong Y. Emerging medical therapies in crush syndrome - progress report from basic sciences and potential future avenues. Ren Fail 2020;42:656-66. [PMID: 32662306 DOI: 10.1080/0886022X.2020.1792928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li N, Chen J, Wang P, Fan H, Hou S, Gong Y. Major signaling pathways and key mediators of macrophages in acute kidney injury (Review). Mol Med Rep 2021;23:455. [PMID: 33880578 DOI: 10.3892/mmr.2021.12094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
12 Straub T, Nave J, Bouvain P, Akbarzadeh M, Dasa SSK, Kistner J, Ding Z, Marzoq A, Stepanow S, Becker K, Hesse J, Köhrer K, Flögel U, Ahmadian MR, French BA, Schrader J, Temme S. MRI-based molecular imaging of epicardium-derived stromal cells (EpiSC) by peptide-mediated active targeting. Sci Rep 2020;10:21669. [PMID: 33303866 DOI: 10.1038/s41598-020-78600-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Boudhabhay I, Poillerat V, Grunenwald A, Torset C, Leon J, Daugan MV, Lucibello F, El Karoui K, Ydee A, Chauvet S, Girardie P, Sacks S, Farrar CA, Garred P, Berthaud R, Le Quintrec M, Rabant M, de Lonlay P, Rambaud C, Gnemmi V, Fremeaux-Bacchi V, Frimat M, Roumenina LT. Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis. Kidney Int 2021;99:581-97. [PMID: 33137339 DOI: 10.1016/j.kint.2020.09.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
14 Giménez VMM, Fuentes LB, Kassuha DE, Manucha W. Current Drug Nano-targeting Strategies for Improvement in the Diagnosis and Treatment of Prevalent Pathologies such as Cardiovascular and Renal Diseases. Curr Drug Targets 2019;20:1496-504. [PMID: 31267869 DOI: 10.2174/1389450120666190702162533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci 2020;21:E5497. [PMID: 32752088 DOI: 10.3390/ijms21155497] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
16 Dukhinova MS, Prilepskii AY, Shtil AA, Vinogradov VV. Metal Oxide Nanoparticles in Therapeutic Regulation of Macrophage Functions. Nanomaterials (Basel) 2019;9:E1631. [PMID: 31744137 DOI: 10.3390/nano9111631] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
17 Tan L, Lai X, Zhang M, Zeng T, Liu Y, Deng X, Qiu M, Li J, Zhou G, Yu M, Geng X, Hu J, Li A. A stimuli-responsive drug release nanoplatform for kidney-specific anti-fibrosis treatment. Biomater Sci 2019;7:1554-64. [PMID: 30681674 DOI: 10.1039/c8bm01297k] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
18 Rubio-Navarro A, Vázquez-Carballo C, Guerrero-Hue M, García-Caballero C, Herencia C, Gutiérrez E, Yuste C, Sevillano Á, Praga M, Egea J, Cannata P, Cortegano I, de Andrés B, Gaspar ML, Cadenas S, Michalska P, León R, Ortiz A, Egido J, Moreno JA. Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury. Front Pharmacol 2019;10:740. [PMID: 31333462 DOI: 10.3389/fphar.2019.00740] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
19 Guerrero-Hue M, García-Caballero C, Palomino-Antolín A, Rubio-Navarro A, Vázquez-Carballo C, Herencia C, Martín-Sanchez D, Farré-Alins V, Egea J, Cannata P, Praga M, Ortiz A, Egido J, Sanz AB, Moreno JA. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J 2019;33:8961-75. [PMID: 31034781 DOI: 10.1096/fj.201900077R] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 28.7] [Reference Citation Analysis]
20 Wang J, Masehi-Lano JJ, Chung EJ. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease. Biomater Sci 2017;5:1450-9. [PMID: 28516997 DOI: 10.1039/c7bm00271h] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 12.3] [Reference Citation Analysis]
21 Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging Strategies of Cancer Therapy Based on Ferroptosis. Adv Mater 2018;30:e1704007. [PMID: 29356212 DOI: 10.1002/adma.201704007] [Cited by in Crossref: 285] [Cited by in F6Publishing: 309] [Article Influence: 71.3] [Reference Citation Analysis]
22 Han HI, Skvarca LB, Espiritu EB, Davidson AJ, Hukriede NA. The role of macrophages during acute kidney injury: destruction and repair. Pediatr Nephrol 2019;34:561-9. [PMID: 29383444 DOI: 10.1007/s00467-017-3883-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
23 Rubio-Navarro A, Sanchez-Niño MD, Guerrero-Hue M, García-Caballero C, Gutiérrez E, Yuste C, Sevillano Á, Praga M, Egea J, Román E, Cannata P, Ortega R, Cortegano I, de Andrés B, Gaspar ML, Cadenas S, Ortiz A, Egido J, Moreno JA. Podocytes are new cellular targets of haemoglobin-mediated renal damage. J Pathol 2018;244:296-310. [PMID: 29205354 DOI: 10.1002/path.5011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
24 Okubo K, Kurosawa M, Kamiya M, Urano Y, Suzuki A, Yamamoto K, Hase K, Homma K, Sasaki J, Miyauchi H, Hoshino T, Hayashi M, Mayadas TN, Hirahashi J. Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat Med. 2018;24:232-238. [PMID: 29309057 DOI: 10.1038/nm.4462] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 19.3] [Reference Citation Analysis]
25 Guerrero-hue M, Rubio-navarro A, Sevillano Á, Yuste C, Gutiérrez E, Palomino-antolín A, Román E, Praga M, Egido J, Moreno JA. Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches. Nefrología (English Edition) 2018;38:13-26. [DOI: 10.1016/j.nefroe.2018.01.003] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Guerrero-hue M, Rubio-navarro A, Sevillano Á, Yuste C, Gutiérrez E, Palomino-antolín A, Román E, Praga M, Egido J, Moreno JA. Efectos adversos de la acumulación renal de hemoproteínas. Nuevas herramientas terapéuticas. Nefrología 2018;38:13-26. [DOI: 10.1016/j.nefro.2017.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Javed Y, Akhtar K, Anwar H, Jamil Y. MRI based on iron oxide nanoparticles contrast agents: effect of oxidation state and architecture. J Nanopart Res 2017;19. [DOI: 10.1007/s11051-017-4045-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
28 Belliere J, Chauveau D, Bascands J, Schanstra J, Faguer S. Mécanismes et prise en charge de la tubulopathie liée à la rhabdomyolyse. Méd Intensive Réa 2016. [DOI: 10.1007/s13546-016-1229-9] [Reference Citation Analysis]